News
Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
Eli Lilly and Company (NYSE:LLY) is one of the most profitable growth stocks to buy according to billionaires. On August 1, ...
9h
GlobalData on MSNMounjaro and Zepbound fuel strong Q2 growth for Eli LillyEli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...
A new study shows that weight loss medication patients can experience hunger, eat well-balanced meals, and still make ...
A WOMAN has revealed how Mounjaro didn’t just help her shed weight, it also saved her son’s life. Shell Giles took to social ...
Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...
Mounjaro manufacturer Eli Lilly has unveiled the test results of its new oral GLP-1 medication, orforglipron. The obesity pill, which is designed to be taken daily by patients who are severely ...
Redditors are complaining their long-term Mounjaro use is causing their hair to fall out in clumps. Experts claim sorting your diet out may fix the issue.
A new study shows that weight loss medication patients can experience hunger, eat well-balanced meals, and still make significant progress ...
While Mounjaro weight-loss injections can help with their waistlines, some users have reported issues with their hairlines ...
An exasperated Copperfield on the trials and tribulations that Mounjaro prescribing has wreaked on general practice ...
Eli Lilly's Q2 earnings soared, fueled by Mounjaro and Zepbound's impressive sales, leading to raised full-year guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results